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Objective: Neuropsychologic disorders are common after coronary artery bypass
operations. Air microbubbles are identified as a contributing factor. A dynamic
bubble trap might reduce the number of gaseous microemboli.
Methods: A total of 50 patients undergoing coronary artery bypass operation were
recruited for this study. In 26 patients a dynamic bubble trap was placed between the
arterial filter and the aortic cannula (group 1), and in 24 patients a placebo dynamic
bubble trap was used (group 2). The number of high-intensity transient signals
within the proximal middle cerebral artery was continuously measured on both sides
during bypass, which was separated into 4 periods: phase 1, start of bypass until
aortic clamping; phase 2, aortic clamping until rewarming; phase 3, rewarming until
clamp removal; and phase 4, clamp removal until end of bypass. S100 values were
measured before, immediately after, and 6 and 48 hours after the operation and
before hospital discharge.
Results: The bubble elimination rate during bypass was 77% in group 1 and 28% in
group 2 (P  .0001). The number of high-intensity signals was lower in group 1
during phase 1 (5.8  7.3 vs 16  15.4, P  .05 vs group 2) and phase 2 (6.9 
7.3 vs 24.2 27.3, P .05 vs group 2) but not during phases 3 and 4. Serum S100
values were equally increased in both groups immediately after the operation. Group
2 patients had higher S100 values 6 hours after the operation and significantly
higher S100 values 48 hours after the operation (0.06  0.14 vs 0.18  0.24, P 
.0133 vs group 2). Age and S100 values were correlated in group 2 but not in
group 1.
Conclusion: Gaseous microemboli can be removed with a dynamic bubble trap.
Subclinical cerebral injury detectable by increases of S100 disappears earlier after
surgical intervention.
Cerebral injury and neuropsychologic deficits after cardiopulmonarybypass are well established in patients undergoing cardiac sur-gery.1,2 Macroemboli and microemboli have both been implicatedin the cause of adverse cerebral outcomes.2-4 Emboli occur duringextracorporeal circulation (ECC), are caused by manipulations ofthe aorta,5,6 and are associated with the technique of cardioplegia7
and the type of oxygenator8,9 or hardshell venous reservoir10 used. Air embolism is
more common after open-chamber procedures11; however, evidence exists that the
majority of microemboli during closed cardiac surgery consists of air.12,13 Trans-
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esophageal echocardiography, carotid ultrasonography,14
and transcranial Doppler ultrasonography were used during
cardiac procedures6,11,15,16 to detect embolic signals within
the aorta17,18 and the arteries supplying the brain. These
embolic events could lead to increased S100 levels.19,20
Clinical and laboratory studies showed a significant reduc-
tion of cerebral microembolic load by using an arterial
filter.7,21,22 In the present study the efficacy of a dynamic
bubble trap (DBT) was investigated in patients undergoing
on-pump coronary artery bypass operations.
Methods
Patients
Fifty patients scheduled for elective coronary artery bypass sur-
gery were randomly assigned in a double-blind manner to one of
2 groups. In group 1 (n  26) a DBT was incorporated in the
arterial line after a common 40-m arterial filter. One patient was
eliminated from the study because of recurring ventricular tachy-
cardia and fibrillation. Group 2 (n  24) was perfused with a DBT
placebo, which was also placed after a 40-m arterial line filter.
Exclusion criteria were as follows: age greater than 75 years;
combined procedures; ejection fraction of less than 35%; athero-
sclerosis of the carotid arteries; combined severe lung, renal, or
cerebral diseases; drug or alcohol abuse; diabetes mellitus; emer-
gency status; and early postoperative complications requiring pro-
longed artificial ventilation and sedation. The investigation interval
was 10 months. The state ethics committee approved the protocol.
Participating patients provided written informed consent.
Transcranial Doppler Ultrasonography
During the operation, bilateral transcranial detection of high-in-
tensity transient signals (HITS) within the proximal middle cere-
bral artery was performed continuously from the beginning to end
of cardiopulmonary bypass with a 2-MHz pulse-wave TCD device
(CDS Neuroguard Plus, Neuroguard Inc). The flat monitoring
Doppler probes were fixed before the ear above the zygomatic
bone (posterior temporal window) with a head frame (Marc 500,
Spencer Technologies). In group 1 middle cerebral artery in-
sonation of both sides was successful in 25 patients, and in group
2 such insonation was successful in 21 patients. In the other 4
patients only the right medial cerebral artery was insonatable (1 in
group 1 and 3 in group 2). The mean insonation depth in group 1
was 50.5 mm (range, 35-68 mm) on the left side and 52.3 mm
(range, 35-68) on the right side; in group 2 the corresponding
depths were 53.6 mm (range, 41-62 mm) and 52.8 (range, 39-62
mm), respectively.
Cerebral Embolus Detection
Automated embolus detection software (EMBOtec Version 5.2,
STAC GmbH) was used. Axial extension of the sample volume
was fixed at 7 mm (high-pass filter at 150 Hz). The color-coded
power spectra of the audible Doppler shift were visualized on
screen (after calculation of a 128-point fast-Fourier transforma-
tion) by using an overlap of 75%.23 Power and gain were individ-
ually adjusted to minimize the intensity of the background color
spectrum and to allow the embolic signals to be completely dis-
played within the dynamic range of the instrument. The audible
Doppler signal was recorded with a digital audio recorder (Tascam
DA-30 MKII, Teac Corp) on digital audiotapes (DT 90RA, Sony
Corp). Two observers manually registered microembolic signals
both online and, if necessary, offline and noted corresponding
surgical events and stages of the operation. The following acoustic
and visual criteria for embolic signals were used: typical visible
high intensity (at least 3 db higher than that of the background
blood-flow signal), typical audible sound (click, chirp, bloop), and
short duration (200 ms). Because the EMBOtec software has not
yet been able to reliably indicate differences between artifacts and
microemboli automatically,24 especially during conditions of
ECC, the investigators arbitrarily rejected signals above and below
the baseline at the presence of obvious artifact. The recording time
was determined on the basis of the duration of bypass. Bypass time
was separated into 4 periods: phase 1, start of ECC until aortic
clamping; phase 2, aortic clamping until rewarming; phase 3,
rewarming until clamp removal; and phase 4, clamp removal until
the end of ECC.
Arterial Line Embolus Detection
A 2-channel Doppler ultrasonography device ultrasonic bubble
counter (Martin Luther University, Halle, Germany) was used to
detect microbubbles before and after the DBT.25 The device counts
microbubbles ranging from 5 to 120 m. Particulate emboli do not
influence the count result. Because of minor clinical relevance,
only bubbles larger than 10 m were taken into account. Hard disk
registration of online data was performed for offline investigation.
Dynamic Bubble Trap
The DBT, which efficiently removes microbubbles, was developed
to reduce the number of microbubbles in the arterial line.26,27 The
DBT was placed in the arterial line between the arterial filter and
arterial cannula (Figure 1). The shape of the DBT is tubular
(Figure 2). It consists of a 3/8-in inlet, a separation chamber, a tube
with a 3/8-in outlet, and a site for collecting microbubbles where
a recirculation line is also connected. Inside the separation cham-
ber there is a 3-channel helix. As blood passes through the helix,
Figure 1. Cardiopulmonary bypass circuit with implementation of
DBT. Oxy, Oxygenator; AF, conventional 40-m arterial line filter;
measure probe, Doppler device. For further explanation, see text.
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it is converted into a rotating stream. The shape of the separation
chamber causes the centrifugal forces to direct air microbubbles to
the center of the flow line. After the blood passes through the tube,
the process stabilizes, with the largest percentage of bubbles now
in the central blood-flow line. The collection site, which is situated
in the center of the distal end of the tube, diverts the central
blood-flow line and returns it together with all bubbles to the
cardiotomy reservoir. Because of the special hydrodynamic fea-
tures of the device, the diversion of flow to the cardiotomy reser-
voir is constant at 400 to 450 mL/min. The efficiency of the bubble
trap depends on many parameters (eg, blood viscosity, tempera-
ture, and position of a microbubble in the blood stream) but mostly
on microbubble size and blood-flow velocity. The mathematic
model, which was set up for the in vitro tests, showed that at least
70% of bubbles with a diameter of 15 m and at least 90% of
larger bubbles (25 m) were removed. Before clinical use, the
biocompatibility of the DBT was tested in an in vitro study.28,29
There was no difference between the DBT group and the control
group. The DBT placebo was a DBT without a helix but with a
collection site and recirculation line to protect the blindness of the
study for the investigators.
Anesthesia Technique
After premedication with flunitrazepam, total intravenous general
anesthesia was induced and maintained with sufentanil and propo-
fol. No volatile anesthetic gases were used. After relaxation with
pancuronium bromide, the trachea was intubated, and controlled
normocapnic ventilation with an air-oxygen mixture was started.
Before or during anesthesia, standard monitors were applied, in-
cluding pulse oximetry, mainstream capnometry, and peripheral
and central body temperature sensors, as well as arterial and pulmo-
nary artery catheters. Blood for arterial blood gas, electrolytes, and
glucose measurement, as well as activated clotting time ascertain-
ment, was sampled according to a standard anesthesia protocol.
Protein S100
Blood samples were taken before, immediately after, and 24 and
48 hours after the end of the operation, as well as before discharge
from the hospital. All blood samples were cooled and centrifuged
immediately and were measured by using a monoclonal 2-sided
immunoradiometric assay (Sangtec 100, AB Sangtec Medical).
Bypass Technique
The DBT (HPmedica) or placebo DBT was integrated into a
standard ECC tubing set (HMT Medizintechnik), which contained
a 40-m heparin-coated arterial line filter (AF 1040 Gold, Baxter).
Extracorporeal perfusion was performed with a roller pump (Sto-
eckert Instrumente) and a hollow-fiber membrane oxygenator with
venous hardshell reservoir (Biocor 200 IHS, Minntech Corp) at a
nonpulsatile flow rate of 2.4 L  min1  m2. The circuit was
primed with 1600 mL of Ringer solution, 100 mL of mannitol
20%, 100 mL of sodium bicarbonate 8.4%, 5000 units of heparin,
and 2 mL of aprotinin. A standard cannulation technique was
performed with a wire inlay aortic arch cannula (diameter, 0.26 in;
length, 8 in; straight 3/8-in connector; Stoeckert), which was
placed in the ascending aorta, as well as with a proximal and distal
wire–reinforced 2-stage venous cannula (F36-32, connector 1/2 in,
Medos Medizintechnik) through the right atrium after systemic
heparinization (500 U/kg). ECC (Stoeckert Instrumente) was ini-
tiated according to the alpha-stat concept. Additional heparin was
added during cardiopulmonary bypass to maintain the activated
clotting time at greater than 400 seconds if necessary. The left
ventricle was vented with an aortic root cannula (diameter, 14-
gauge; length, 5.6 in; Stoeckert Instrumente). After reaching mod-
erate hypothermia, distal graft anastomoses were performed during
aortic crossclamping. For myocardial preservation, Bretschneider
Cardioplegia (Custodiol, Dr Franz Koehler Chemie, Alsbach-
Ha¨hnlein, Germany) was administered to achieve and sustain
cardiac arrest. After the removal of the crossclamp, proximal
anastomoses were made after tangential clamping of the aorta
during rewarming. Weaning from ECC happened after watching
the reperfusion time (one third of the crossclamp time) to recover
normal myocardial function and reaching normothermic core tem-
perature. If necessary, intravenous dopamine was infused at 3 to 5
g  kg1  min1 to enhance cardiac inotropy.
Statistical Analysis
The data were collected with a computer database (SigmaPlot 4.01,
SPSS Corp). Statistical analysis was performed with the DataDesk
software (v6.1, Data Description Inc). All values are expressed as
mean  SD if normally distributed or median with range. Statis-
tical significance regarding the differences between groups was
determined with a 2-sample Student t test for normally distributed
data or with the nonparametric Mann-Whitney rank sum test.
Results
According to the study design, one female patient of group
1 was excluded because of hemodynamic instability caused
by recurring ventricular tachycardia and fibrillation. Post-
operative records of all patients were uncomplicated. They
could be extubated within 12 hours and left the intensive
care unit after 1 day (mean intensive care unit stay, 1.04
days). Neurologic examinations of all patients on the second
and third day postoperatively were normal. The biometric
data of the 2 groups did not differ concerning sex and key
body figures. Overall, 41 men and 8 women were included
in both groups. Intraoperative data are summarized in Table
1. The bubble elimination rate of the DBT (defined as
Elimination rate  [Bubbles before DBT  Bubbles after
DBT)/Bubbles before DBT]) was 81% in group 1 and 36%
in group 2.
Figure 2. The DBT in detail: 1, Separation chamber; 2, 3/8-in inlet;
3, tube with 3/8-in outlet; 4, collection site; 5, 3-channel helix. For
further explanation, see text.
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After the blood of group 1 patients passed the DBT, it
contained significantly fewer bubbles than the blood of
group 2 patients after passing the placebo DBT. The results
of bubble detection in the arterial line are shown in Table 2.
Transcranial Doppler emboli detection showed 2 to 3 times
more HITS in group 2 compared with those in group 1 as far
as total bypass time and different phases of bypass are
concerned. These differences were significant, except in
phases 3 and 4 (Table 3). Serum S100 values were in-
creased in both groups at the end of the operation compared
with preoperative values. A comparison between the groups
at the 5 different time points showed higher S100 values in
group 2 (Table 4). This difference is significant 48 hours
postoperatively (P  .0133) and has a strong tendency 6
hours postoperatively (P  .11; not significant but small
enough to suggest a tendency). Regression analysis between
age and S100 values showed a correlation in group 1 (R
0.42, P  .05) but not in group 2.
Discussion
Doppler ultrasonography was used to detect cerebral emboli
during coronary artery bypass surgery.17 The majority of
emboli are detected after release of the aortic crossclamp
and partial occlusion clamp. It has therefore been suggested
that these signals mostly represent atheromatous debris
rather than gaseous microbubbles. Reichenspurner and col-
leagues30 showed that an intra-aortic filtration system could
effectively catch these particles (fibrous atheroma, medial
tissue, epiaortic debris, and thrombus material).
Many studies suggest that use of a 40-m arterial filter in
the arterial line of the ECC might also reduce microemboli.
Our study shows that gaseous microemboli detected after
the arterial filter ranged from 415 to 16,442 bubbles in the
DBT group and from 453 to 6,114 bubbles in the placebo
group. We conclude that this situation necessitates supple-
mental measures to remove this air from the extracorporeal
bypass circuit.
The DBT effectively eliminated a large percentage of
these microbubbles. However, after the placebo, we also
measured a minor reduction of microbubbles (2042 vs 1409,
TABLE 2. Number of bubbles in arterial line of bypass
circuit
Parameter Group Mean SD Median Range P value
Before trap DBT 2825 3180 1921 16,442 .435
Dummy 2042 1420 1587 6114
After trap DBT 520 419 418 1550 .001
Dummy 1409 840 1921 3069
TABLE 1. Biometric and intraoperative data of both groups (DBT  group 1, Dummy  group 2)
Parameter Group Mean SD Median Range P value
Age (y) DBT 63.8 8.5 66.3 33.3 .118
Dummy 60.1 7.7 59.9 32.1
BSA (m2) DBT 1.94 0.18 1.95 33.3 .193
Dummy 2.01 0.2 1.98 32.1
ECC time (min) DBT 71 17 71 73 .069
Dummy 82 23 77 91
Body temperature
(°C)
DBT 27 1.3 27 5.9 .955
Dummy 26.9 1.5 26.6 7
No. of arterial grafts DBT 1.32 0.748 1 3 .167
Dummy 1.7 0.91 1.5 3
No. of venous grafts DBT 1.76 0.88 2 4 .342
Dummy 2.04 1.16 2 4
pH DBT 7.369 0.041 7.41 0.18 .117
Dummy 7.365 0.086 7.375 0.44
PCO2 (mm Hg) DBT 44.13 3.314 34 22 .369
Dummy 45.13 4.266 44.5 13
PO2 (mm Hg) DBT 273 107 246 396 .375
Dummy 282 98 266 482
Hbg (g/100 mL) DBT 7.3 0.72 7.2 3 .187
Dummy 7.6 1.1 7.4 4.4
Mean AP (mm Hg) DBT 40.8 9.7 38 28 .372
Dummy 43.4 10.9 42 42
mFV re (cm/s) DBT 28.4 6.2 28 22 .377
Dummy 26.7 7.3 24 29
mFV li (cm/s) DBT 28.3 5.9 28 22 .756
Dummy 29 8.2 27 32
BSA, Body surface area; Bodytemp, mixed venous blood temperature after aortic crossclamping; Hgb, hemoglobin sampled in phase 2; mean AP, mean
arterial pressure in phase 2; mFV, mean flow velocity in both middle cerebral arteries.
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P  .001). The explanation for this is that a DBT without a
helix was used as the placebo. The shape of the separation
chamber and the existence of the collection site and recir-
culation line resulted in a minor reduction of microbubbles.
Even a simple tube (without a separation chamber but with
a collection site and recirculation flow) would show a low
efficacy. Transcranial Doppler ultrasonography in the mid-
dle cerebral arteries showed significant reductions of emboli
in the DBT group compared with that seen in the placebo
group, but the numbers in both groups are one decimal
power lower than those in the arterial bypass line. Obvi-
ously a large number of bubbles have traveled to other parts
of the body or to anterior and posterior cerebral regions.
The bubble-reducing effect of the DBT is most pro-
nounced during phases 1 and 2. At the beginning of CPB,
the number of microbubbles per minute measured in the
arterial line is high because of remaining air in the venous
line at the initiation of cardiopulmonary bypass. In phase 2
the manipulation at the ascending aorta after crossclamping
is relatively rare, but air introduced by means of blood
sampling and drug administration by the perfusionist or
over leaking purse-string sutures of the venous cannula
during heart manipulation does occur far more frequently.
This air can be successfully removed by the DBT.
In phases 3 and 4 embolic signals are predominantly
caused by solid particles originating from manipulations of
the aorta, such as partial crossclamping and removal of the
aortic vent.3,5,30 Therefore the DBT has no effect on this
origin of cerebral HITS.
An increased level of serum S100 in patients with
uneventful clinical outcomes might provide evidence of
subclinical injury, which could be due to diffuse microem-
boli and increased permeability of the blood-brain barrier,
but not irreversible cerebral damage through neuronal isch-
emia and death.31 Lloyd and associates32 showed similar
S100 values in 30 on-pump patients for coronary artery
bypass surgery without any finding of cerebral damage. The
lower air embolic load in this group, which lays bare the
negative effect of age on cerebral outcome, can explain the
phenomenon of age dependency of S100 levels in the DBT
group. In the placebo group all age brackets are similarly
affected by microemboli, so that the age dependency is hidden.
Conclusion
Cardiopulmonary perfusion–aided coronary artery bypass
surgery allows particulate and gaseous microemboli to enter
the cerebral perfusion of the patient. Gaseous microemboli
can be effectively removed by the DBT. However, the DBT
is not able to prevent emboli originating from the aorta
itself, although it is a helpful adjunct to reduce the total
embolic load to the cerebral perfusion. Subclinical cerebral
injury detectable by mild increases of S100 protein disap-
pears earlier after the operation when using the DBT.
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